Intraoperative Radiation Therapy Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 6.30 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
| Market Concentration | High |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Intraoperative Radiation Therapy Market Analysis
The intraoperative radiation therapy market is expected to record a CAGR of 6.3% over the forecast period.
COVID-19 significantly impacted the intraoperative radiation therapy market. Various screening, diagnostics, and surgical procedures were restricted or postponed at hospitals and cancer treatment centers, disrupting cancer diagnosis and treatment procedures. As per a research study published in October 2021 by the Journal of Medical Screening, during the pandemic, breast cancer screening was affected globally as many countries such as Canada, the Netherlands, Germany, Italy, the United Kingdom, and Australia halted their breast screening programs in response to COVID-19. Thus, this led to a decline in the diagnosis of cancer and severely impacted the market's growth. However, the market has recovered well due to a decline in COVID-19 cases and the resumption of diagnostic and screening processes globally. It is anticipated to gain traction due to an increase in cancer cases throughout the forecast period.
An increase in the incidence and prevalence of cancer globally is projected to drive the intraoperative radiation therapy market during the forecast period. The most common cancers are breast cancer, lung and bronchus cancer, prostate cancer, colon and rectum cancer, melanoma of the skin, bladder cancer, non-Hodgkin lymphoma, kidney and renal pelvis cancer, endometrial cancer, leukemia, pancreatic cancer, thyroid cancer, and liver cancer. According to the Breast Cancer Factsheet Now 2021, around 55,000 women and 370 men in the United Kingdom are diagnosed with breast cancer every year. This figure is expected to climb to 1.2 million by 2030. Thus, the huge prevalence of cancer cases is likely to increase the demand for radiation therapy, thereby boosting the market's growth over the forecast period.
Besides, increasing demand for highly efficient radiation therapy systems for cancer treatment, new product approvals, and fundraising are projected to augment the intraoperative radiation therapy market during the forecast period. For instance, in October 2022, PLANET successfully raised GBP 1 million for a ground-breaking radiation system to fully purchase Mobetron, a cutting-edge mobile device that administers intraoperative radiotherapy during surgery.
However, the lack of skilled personnel to operate the equipment and preference for conventional radiotherapy over IORT may hinder the market's growth.
Intraoperative Radiation Therapy Market Trends
Electron IORT Segment is Expected to Hold Significant Market Share Over the Forecast Period
Electron intraoperative radiation therapy or intraoperative electron radiation therapy (IOERT) is the application of electron radiation directly to the residual tumor or tumor bed during cancer surgery. Electron beams are useful for intraoperative radiation treatment as the dose falls off rapidly behind the target site depending on the electron energy, sparing underlying healthy tissue. Besides, intraoperative radiation therapy revolutionized the traditional model by administering radiation during surgery. It is safer and more accurate and saves considerable time for both the hospital and patients. The clinical data also confirm that successful outcomes with IORT are more consistent. Thus, the positive outcomes associated with the IORT are contributing to the market's growth.
According to the REDECAN study published in November 2022, breast cancer is the most frequent cancer and the primary cause of cancer-related death in women in Spain, with 34,750 women diagnosed with it in 2022. As per the same source, there were 30,948 new cases of lung cancer diagnosed in Spain in 2022. Thus, the huge prevalence of cancer and the need for early diagnostics are expected to increase, supporting the segment's expansion over the forecast period.
North America Holds Significant Share in the Market and is Expected to Retain the Same Over Forecast Period
North America is expected to dominate the overall intraoperative radiation therapy market throughout the forecast period, attributed to factors such as the increasing prevalence and incidence of cancers. The United States is expected to be the largest market in the region.
The significant burden of cancer is anticipated to drive the demand for radiotherapy in the region. For instance, according to the American Cancer Society's data in January 2023, an estimated 1.95 million new cancer cases are likely to be diagnosed in the United States in 2023, among which prostate cancer is estimated to account for 186,670 new cases, followed by 169,870 cases of lung cancer and 144,490 cases of female breast cancer. According to statistics by the Government of Canada, released in November 2021, about 229,200 Canadians were diagnosed with cancer in 2021, and prostate cancer was the most diagnosed cancer, accounting for 46% of all cancer diagnoses in 2021. Thus, the country's huge incidence and prevalence of cancer are demanding advanced therapeutics treatment, which is further predicted to boost the overall market's growth in the region.
Besides, well-established healthcare infrastructure and market players undertaking various research activities are also contributing to the market's growth. For instance, in September 2021, SkinCure Oncology declared positive results from a clinical trial, showing positive data (99.3% cure rate) for Image-Guided Superficial Radiotherapy (IGSRT) in treating basal cell carcinoma (BCC) and squamous cell carcinoma (SCC).
Hence, due to such factors, North America is anticipated to create opportunities for intraoperative radiation therapy, driving the overall market's growth over the forecast period.
Intraoperative Radiation Therapy Industry Overview
The intraoperative radiation therapy market is highly competitive. Major players in the market are implementing various strategies, such as launching new products and focusing on mergers and acquisitions, to consolidate their market positions across the world. Some of the market players are Ariane Medical Systems Ltd, Eckert & Ziegler, Elekta AB Inc., Sensus Healthcare Inc., Sordina IORT Technologies, and Carl Zeiss Meditec AG.
Intraoperative Radiation Therapy Market Leaders
-
Eckert & Ziegler
-
Carl Zeiss Meditec AG
-
Sensus Healthcare Inc.
-
Ariane Medical Systems Ltd
-
Sordina IORT Technologies
*Disclaimer: Major Players sorted in no particular order
Intraoperative Radiation Therapy Market News
- In March 2022, Zeiss Medical Technology introduced INTRABEAM 600 device to provide Intraoperative Radiation Therapy (IORT) in India. INTRABEAM 600, Zeiss Meditec's IORT device, offers the least disruptive treatment method available to patients diagnosed with early-stage breast cancer.
- In February 2022, Fortis Cancer Institute announced the installation of Karnataka's first Intraoperative radiotherapy (IORT) system for the treatment of breast cancer.
Intraoperative Radiation Therapy Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Growing Global Prevalence of Cancer
- 4.2.2 Advancements in Cancer Therapy Technologies
- 4.2.3 Advantages of IORT Over External Beam Radiotherapy
-
4.3 Market Restraints
- 4.3.1 Limitations of IORT and Shortage of Trained Personnel
- 4.3.2 Preference for Conventional Radiotherapy Over Intraoperative Radiation Therapy
-
4.4 Industry Attractiveness - Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
-
5.1 By Method
- 5.1.1 Electron IORT
- 5.1.2 Intraoperative Brachytherapy
- 5.1.3 Other Methods
-
5.2 By Products and Services
- 5.2.1 Products
- 5.2.1.1 Systems/Accelerators
- 5.2.1.2 Applicators and Afterloaders
- 5.2.1.3 Treatment Planning Systems
- 5.2.1.4 Accessories
- 5.2.2 Services
-
5.3 By Application
- 5.3.1 Breast Cancer
- 5.3.2 Brain Tumor
- 5.3.3 Gastrointestinal Cancer
- 5.3.4 Head and Neck Cancer
- 5.3.5 Other Applications
-
5.4 By Geography
- 5.4.1 North America
- 5.4.1.1 United States
- 5.4.1.2 Canada
- 5.4.1.3 Mexico
- 5.4.2 Europe
- 5.4.2.1 Germany
- 5.4.2.2 United Kingdom
- 5.4.2.3 France
- 5.4.2.4 Italy
- 5.4.2.5 Spain
- 5.4.2.6 Rest of Europe
- 5.4.3 Asia-Pacific
- 5.4.3.1 China
- 5.4.3.2 Japan
- 5.4.3.3 India
- 5.4.3.4 Australia
- 5.4.3.5 South Korea
- 5.4.3.6 Rest of Asia-Pacific
- 5.4.4 Middle East and Africa
- 5.4.4.1 GCC
- 5.4.4.2 South Africa
- 5.4.4.3 Rest of Middle East and Africa
- 5.4.5 South America
- 5.4.5.1 Brazil
- 5.4.5.2 Argentina
- 5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Ariane Medical Systems Ltd
- 6.1.2 Eckert & Ziegler
- 6.1.3 Elekta AB
- 6.1.4 GMV Innovating Solutions
- 6.1.5 ICAD Inc.
- 6.1.6 Intraop Medical Corporation
- 6.1.7 Sensus Healthcare Inc.
- 6.1.8 Sordina IORT Technologies
- 6.1.9 Varian Medical Systems Inc.
- 6.1.10 Carl Zeiss Meditec AG
- 6.1.11 Isoray Inc.
- 6.1.12 Varian Medical Systems
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityIntraoperative Radiation Therapy Industry Segmentation
As per the report's scope, intraoperative radiation therapy (IORT) is an intensive radiation treatment administered during surgery. IORT allows direct radiation to the target area while sparing normal surrounding tissue. IORT is used to treat cancers that are difficult to remove during surgery and when there is a concern that microscopic amounts of cancer may remain.
The intraoperative radiation therapy market is segmented by method (electron iort, intraoperative brachytherapy, and other methods), products and services (product and services), application (breast cancer, brain tumor, gastrointestinal cancer, head and neck cancer, and other applications), and geography (North America, Europe, Asia Pacific, Middle East and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.
| By Method | Electron IORT | |
| Intraoperative Brachytherapy | ||
| Other Methods | ||
| By Products and Services | Products | Systems/Accelerators |
| Applicators and Afterloaders | ||
| Treatment Planning Systems | ||
| Accessories | ||
| By Products and Services | Services | |
| By Application | Breast Cancer | |
| Brain Tumor | ||
| Gastrointestinal Cancer | ||
| Head and Neck Cancer | ||
| Other Applications | ||
| By Geography | North America | United States |
| Canada | ||
| Mexico | ||
| By Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| By Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| By Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| By Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Intraoperative Radiation Therapy Market Research FAQs
What is the current Intraoperative Radiation Therapy Market size?
The Intraoperative Radiation Therapy Market is projected to register a CAGR of 6.30% during the forecast period (2024-2029)
Who are the key players in Intraoperative Radiation Therapy Market?
Eckert & Ziegler, Carl Zeiss Meditec AG, Sensus Healthcare Inc., Ariane Medical Systems Ltd and Sordina IORT Technologies are the major companies operating in the Intraoperative Radiation Therapy Market.
Which is the fastest growing region in Intraoperative Radiation Therapy Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Intraoperative Radiation Therapy Market?
In 2024, the North America accounts for the largest market share in Intraoperative Radiation Therapy Market.
What years does this Intraoperative Radiation Therapy Market cover?
The report covers the Intraoperative Radiation Therapy Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Intraoperative Radiation Therapy Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Netherlands In Vitro Diagnostics Industry Report
Statistics for the 2024 Netherlands In Vitro Diagnostics market share, size and revenue growth rate, created by Mordor Intelligenceā¢ Industry Reports. Netherlands In Vitro Diagnostics analysis includes a market forecast outlook 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
